Related by context. All words. (Click for frequent words.) 72 colorectal adenoma 71 urothelial carcinoma 70 gastric adenocarcinoma 69 histologic subtype 69 oesophageal adenocarcinoma 69 ADPKD 69 Helicobacter pylori infection 69 gallstone disease 68 nasopharyngeal carcinoma 68 clinicopathological 68 malignant lymphoma 68 GSTT1 68 HNSCC 67 gastric cardia 67 advanced adenoma 67 gastric carcinoma 67 oesophageal squamous cell carcinoma 67 prostate cancer CaP 67 cutaneous melanoma 67 coronary calcification 67 renal cell carcinomas 67 astrocytomas 67 abdominal adiposity 67 MGUS 67 colorectal carcinoma 67 CP CPPS 66 prostate cancer PCa 66 Cholangiocarcinoma 66 leiomyomas 66 neoplasias 66 arterial calcification 66 serous ovarian cancer 66 SSc 66 neoplasm 66 autonomic dysfunction 66 diabetes mellitus DM 66 basal cell carcinoma BCC 66 nonalcoholic steatohepatitis NASH 66 cell carcinomas 66 nodal metastasis 66 colorectal tumors 66 grade cervical intraepithelial 66 invasive ductal 66 mesotheliomas 66 monogenic 66 carcinoid tumors 66 pancreatic adenocarcinoma 66 colorectal adenocarcinoma 66 epithelial tumors 65 testicular germ cell 65 PCa 65 hormone receptor negative 65 urothelial cancer 65 hepatoma 65 liver metastasis 65 obstructive coronary artery 65 pulmonary metastases 65 urothelial 65 SNP rs# [001] 65 endometrial carcinoma 65 primary hyperparathyroidism 65 thyrotropin 65 papillary renal cell carcinoma 65 ductal adenocarcinoma 65 E selectin 65 metaplasia 65 granulomatous 65 Papillary 65 familial pancreatic cancer 65 hyperhomocysteinemia 65 metachronous 65 histological subtype 65 atypical hyperplasia 65 nonmetastatic 65 Leydig cell 65 etiologic agent 65 endometrial hyperplasia 65 NAT2 65 Gorlin syndrome 65 kaempferol 64 NR#A# 64 prostate carcinoma 64 gastric cancers 64 seminomas 64 distal colon cancer 64 Cryptococcus neoformans 64 lymphoproliferative disorders 64 atrophic gastritis 64 carcinoid tumor 64 Epstein Barr virus EBV 64 CIN3 64 Gastric cancer 64 Chronic pancreatitis 64 GSTP1 64 gene polymorphism 64 hyperplastic 64 gene polymorphisms 64 adenocarcinomas 64 basal cell nevus syndrome 64 HepG2 cells 64 nonmelanoma 64 B7 H3 64 MALT lymphoma 64 HGPIN 64 serum urate levels 64 mucinous 64 heterozygotes 64 TT genotype 64 systemic amyloidosis 64 pulmonary metastasis 64 lymph node metastasis 64 penetrance 64 colorectal cancer CRC 64 adenomatous 64 EBV infection 64 nodal metastases 64 cutaneous squamous cell carcinoma 64 colorectal adenomas 64 IDH1 mutation 64 precursor lesions 64 extramedullary 64 chronic prostatitis 64 invasive lobular 64 PTEN protein 64 prognostic significance 64 lung carcinomas 63 Genetic variation 63 elevated triglyceride levels 63 hamartomas 63 subclinical atherosclerosis 63 HBeAg negative 63 hepatocellular carcinomas 63 hypercalciuria 63 protein tyrosine phosphatase 63 hepatocellular carcinoma 63 T2D 63 TGF alpha 63 Soy isoflavones 63 BRAF V#E 63 GSTM1 63 H pylori 63 macroalbuminuria 63 nonmelanoma skin cancers 63 malignant neoplasm 63 LRP5 63 alanine aminotransferase ALT 63 rs# [004] 63 ductal breast cancer 63 carotid atherosclerosis 63 cholangiocarcinoma 63 fulminant hepatic failure 63 atherosclerotic lesion 63 serum homocysteine 63 thyroid carcinoma 63 advanced adenomas 63 chronic periodontitis 63 ERalpha 63 NKX2 63 rs# [001] 63 HER2 expression 63 GISTs 63 osteosarcomas 63 rs# [002] 63 etiologic 63 inducible nitric oxide synthase 63 parkinsonism 63 familial clustering 63 vulvar intraepithelial neoplasia 63 dysglycemia 63 N telopeptide 63 Fas ligand 63 hematopoietic cancers 63 breast carcinomas 63 hepatocellular carcinoma HCC 63 PTPN# 63 adrenocortical 63 RRM1 63 Candida infection 63 cardiac dysfunction 63 metastatic gastric 63 SNP rs# [002] 63 isoenzymes 63 ABCB1 63 artery stenosis 63 reflux esophagitis 63 bronchial epithelial cells 63 Immunohistochemical analysis 63 node metastases 63 Epstein Barr Virus EBV 63 #F FDG PET 63 chorioamnionitis 63 bladder cancers 63 cervical neoplasia 63 clinicopathologic 63 polyp recurrence 63 leucopenia 63 nonmelanoma skin cancer 63 aminotransferase 63 Adenomas 63 PCNSL 63 hepatic fibrosis 63 IGFBP 63 Apolipoprotein E 63 grade gliomas 63 lung adenocarcinomas 63 CDH1 63 thiopurine 63 premalignant lesions 63 antitumor effect 63 oropharyngeal cancer 63 mucosal inflammation 63 ductal cancer 62 TGF ß1 62 lichen planus 62 esophageal cancers 62 urolithiasis 62 carotid stenosis 62 adenoma 62 intestinal metaplasia 62 hematologic toxicity 62 atherosclerotic lesions 62 HLA DRB1 62 ovarian carcinoma 62 carotid artery thickness 62 supratentorial 62 T1a 62 Genetic variants 62 murine model 62 cerebral infarction 62 paraneoplastic 62 Sjögren syndrome 62 peritoneal carcinomatosis 62 lobular carcinoma 62 leukocyte counts 62 idiopathic PAH 62 DRB1 * 62 CC genotype 62 homocysteine concentrations 62 calculi 62 N. gonorrhoeae 62 steroidogenic 62 thrombocytopenic 62 locoregional recurrence 62 lobular breast cancer 62 liver transplant recipients 62 invasive ductal carcinoma 62 HSV1 62 pDC 62 cranial irradiation 62 epithelioid 62 airway hyperresponsiveness 62 squamous cell carcinoma SCC 62 Glioma 62 spermidine 62 lipid abnormalities 62 esophageal adenocarcinoma 62 TCF#L# 62 IPAH 62 basal cell carcinomas 62 Multivariate analysis 62 activin 62 TGF ß 62 baseline LDH 62 renal tumors 62 hereditary predisposition 62 cytokeratin 62 ovarian pancreatic 62 chlamydial infection 62 flavonoid intake 62 bullous 62 receptor inhibitor 62 thyrotropin levels 62 glomerular 62 malondialdehyde 62 neuritic 62 anaplastic 62 Angiotensin converting enzyme 62 Endometrial 62 germline mutations 62 bronchoalveolar 62 neurofibromas 62 metastatic lymph nodes 62 vaginal lesions 62 coinfection 62 TNFalpha 62 serum GGT 62 desmoplastic 62 mammary tumors 62 interstitial pneumonia 62 folate deficiency 62 bladder tumors 62 thymoma 62 serum parathyroid hormone 62 CVD mortality 62 lung adenocarcinoma 62 colorectum 62 ERK signaling 62 carcinoid 62 neurological manifestations 62 Synovial sarcoma 62 hepatic cirrhosis 62 Leukemias 62 microsatellite instability 62 pancreatic prostate 62 nonhereditary 62 PsA 62 fluoroquinolone resistant 62 breast carcinoma 62 postoperative AF 62 gynecologic malignancy 62 liver histology 62 prostate carcinogenesis 62 papillary RCC 62 susceptibility loci 62 HER2 overexpression 62 SGPT 62 MSH2 61 EoE 61 breast endometrial 61 disease NAFLD 61 genetic loci 61 carotid plaques 61 squamous cell lung cancer 61 recurrent venous thromboembolism 61 mRNA expression 61 elevated CRP 61 Basal Cell 61 ANCA associated 61 transitional cell carcinoma 61 isoprostane 61 intestinal polyps 61 missense mutations 61 genetic polymorphisms 61 Hematologic 61 hepatocellular cancer 61 anaplastic astrocytomas 61 perioperative morbidity 61 hyperparathyroidism 61 fibrin deposition 61 transferrin saturation 61 sCJD 61 MetS 61 Non Alcoholic Fatty 61 SOD2 gene 61 Estrogen Receptor 61 ALDH2 61 PNET 61 sarcosine 61 elevated serum creatinine 61 Mycoplasma pneumoniae 61 Diabetic nephropathy 61 poorer prognosis 61 lobular 61 lymphovascular invasion 61 Chronic lymphocytic leukemia 61 pathogenetic 61 Liver cirrhosis 61 graft dysfunction 61 nephrolithiasis 61 AST ALT 61 uveal melanoma 61 SNCA 61 transgenic rats 61 hypoperfusion 61 immunohistochemical 61 STAT4 61 distant metastasis 61 atherosclerotic vascular disease 61 colorectal polyp 61 NMIBC 61 hamartoma 61 C. neoformans 61 IDDM 61 hepatic steatosis 61 prognostic indicator 61 urinary bladder cancer 61 TCF#L# gene 61 papillary 61 DNA methylation patterns 61 K ras mutations 61 tHcy 61 Adiposity 61 histologic subtypes 61 amenorrhoea 61 invasive carcinoma 61 T. vaginalis 61 orchitis 61 postoperative delirium 61 SRBD 61 pituitary adenomas 61 cellularity 61 FDG PET imaging 61 rCBF 61 narcolepsy cataplexy 61 neurodevelopmental outcome 61 biochemical abnormalities 61 genital herpes infections 61 SMAD4 61 immunocompetent 61 seropositivity 61 cystatin C 61 thyroid nodules 61 subclinical hyperthyroidism 61 selenium intake 61 gamma tocopherol 61 biliary tract cancers 61 mitochondrial toxicity 61 p# mutations 61 precancerous cervical 61 lymphocytic 61 LV dysfunction 61 beta1 integrin 61 CagA 61 MSMB 61 invasive carcinomas 61 Amino acid 61 serum IGF 61 oligodendrogliomas 61 VEGF expression 61 untreated celiac disease 61 collagenous colitis 61 pheochromocytoma 61 neurologic complications 61 overt hypothyroidism 61 cervical carcinoma 61 hereditary hemochromatosis 61 cryptoxanthin 61 triacylglycerol concentrations 61 bronchoalveolar lavage fluid 61 choriocarcinoma 61 Chlamydia trachomatis infection 61 behavioral disinhibition 61 proteoglycan 61 triglyceride concentrations 61 serum selenium 61 elevated ALT 61 ADAMTS# 61 Endometrial cancer 61 ZNF# 61 obstructive coronary 61 breast cancer metastasis 61 #ß 61 proximal colon 61 autosomal dominant polycystic kidney 61 2 diabetes T2D 61 distant metastases 61 fetuin 61 plasminogen activators 61 oral squamous cell 61 metabolic dysfunction 61 VLDL cholesterol 61 Clusterin 61 ovarian hormones 61 Genetic predisposition 61 osteoprotegerin 61 hypermethylated 61 enterocolitis 61 skeletal fluorosis 61 interleukin IL -6 61 CYP#B# 61 pancreatic lung 61 CIN2 + 61 elevated homocysteine 61 colorectal neoplasia 61 telomere lengths 61 bacteriuria 61 lignan intake 61 pleomorphic 61 methicillin susceptible Staphylococcus aureus 61 alveolar epithelial cells 61 lung metastases 61 transgene expression 61 Metastases 61 aortic atherosclerosis 61 lipoxygenase 61 p#INK#a 61 Oxidative damage 61 bladder carcinoma 61 carotid plaque 61 C. trachomatis 61 mitochondrial metabolism 61 proinflammatory cytokine 61 hypophosphatemia 61 TIMP 61 atherothrombotic disease 61 FGFR3 61 gastric mucosa 61 colorectal gastric 61 premalignant 61 neoplasms 61 inherited mutations 61 mesenteric 61 APOE e4 61 Polymorphisms 61 squamous 61 trophoblast cells 61 cancerdefine 61 Adenocarcinoma 61 Ischemic heart 61 fibrosarcoma 61 acute rheumatic fever 61 visceral adiposity 61 antiproliferative effects 61 Chronic HCV 61 gastrointestinal perforation 61 folate intake 60 cirrhosis liver failure 60 malignant prostate 60 antigen PSA levels 60 pheochromocytomas 60 eosinophilic 60 thromboembolic complications 60 cerebral vasospasm 60 intraepithelial 60 Genetic mutation 60 proliferative diabetic retinopathy 60 Histologic 60 HER2 amplification 60 urine NGAL 60 T1DM 60 hepatocellular 60 diabetic microvascular complications 60 IgE antibody 60 gastric carcinogenesis 60 type2 diabetes 60 chronic hepatitis cirrhosis 60 predisposing factor 60 hormone receptor status 60 CXCR4 expression 60 NAFLD 60 neoplasia 60 cervical lymph nodes 60 Asymptomatic 60 Lymph node 60 apo AI 60 activated microglia 60 GABHS 60 relapsed MM 60 PHPT 60 IGFBP 3 60 underlying vasculopathy 60 acute myeloid 60 COX2 60 #q#.# [001] 60 neoplastic lesions 60 mononuclear cells 60 Iron deficiency anemia 60 histopathologic examination 60 multimodality therapy 60 Aortic stenosis 60 paragangliomas 60 AhR 60 adrenocortical cancer 60 C. pneumoniae 60 enteroviral infection 60 plasma lipid 60 functional polymorphism 60 HIV HCV coinfected 60 recurrent VTE 60 serum TSH 60 BRCA1 mutations 60 SLC#A# [001] 60 Hashimoto thyroiditis 60 haemorrhagic 60 Thyroid hormone 60 Acute myeloid leukemia 60 sitosterol 60 lymph node metastases 60 cell adhesion molecule 60 genes differentially expressed 60 microvascular dysfunction 60 C. perfringens 60 RASSF1A 60 hyperinsulinemia 60 effector function 60 esophageal carcinoma 60 immunoreactivity 60 central adiposity 60 PAOD 60 cyclin dependent kinase inhibitor 60 Chlamydia pneumoniae 60 eosinophil count 60 paraganglioma 60 carotid IMT 60 urothelium 60 GNAQ 60 aneuploid cells 60 HLA DRB1 * 60 mIU L 60 estrone 60 HDL2 60 histologic 60 clinically detectable 60 carcinoids 60 H. pylori infection 60 atopic disease 60 nodular melanoma 60 endothelial activation 60 intrahepatic 60 nonalcoholic steatohepatitis 60 impaired insulin secretion 60 Histoplasma capsulatum 60 tocopherol 60 soluble CD# ligand 60 serum PTH 60 enteroviral 60 malignant pleural mesothelioma 60 ductal lobular 60 allogeneic HSCT 60 epithelial ovarian cancer 60 grade squamous intraepithelial 60 colorectal neoplasms 60 Bacterial infection 60 Sezary syndrome 60 hyperalgesia 60 chitinase 60 cervical intraepithelial neoplasia 60 ERCC1 60 intracranial hypertension 60 atypia 60 Elevated serum 60 pre cancerous lesion 60 HMGA2 60 HNPCC 60 colorectal tumor 60 APOL1 60 HLA B# 60 somatic mutation 60 gastrointestinal stromal tumors GISTs 60 rs# [003] 60 methylenetetrahydrofolate reductase 60 differentiated thyroid 60 p# activation 60 Plasmodium vivax 60 trans palmitoleate 60 Butyrate 60 vascular endothelial 60 B Cell Lymphoma 60 sarcomatoid 60 primary aldosteronism 60 parasitaemia 60 NQO1 60 LRAT 60 nephrogenic 60 tumor histology 60 anterior uveitis 60 Squamous cell 60 cardiac fibrosis 60 cholelithiasis 60 MGd 60 metabolizing enzymes 60 trabecular bone 60 follicular thyroid cancer 60 HbF 60 Squamous 60 pulmonary dysfunction 60 fluoroquinolone resistance 60 nonischemic 60 Genotypes 60 skeletal metastases 60 GPC5 60 NNRTI resistance 60 oxidized phospholipids 60 metabolic syndrome MetS 60 distinct subtypes 60 VUR 60 papillomas 60 oropharyngeal squamous cell carcinoma 60 Nilotinib 60 serum calcium 60 serum leptin 60 t# c# CLA 60 periventricular leukomalacia 60 bronchogenic carcinoma 60 multivariable analysis 60 autoimmune pancreatitis 60 Haptoglobin 60 operable breast cancer 60 androgen receptor AR 60 phytoestrogen intake 60 plasma adiponectin 60 astrocytoma 60 PB1 F2 60 pathological hallmark 60 lymphoid cells 60 chromosome #p#.# 60 de novo mutations 60 biochemical relapse 60 follicular lymphoma FL 60 endocrine tumors 60 osteoblast activity 60 prognostic markers 60 arterial stiffening 60 TIMP 1 60 chronic gastritis 60 pT2 60 neovascular 60 transaminase elevations 60 cardiolipin 60 microglial 60 serum PSA 60 autoimmune thyroid 60 International Prognostic Scoring 60 papillary thyroid cancer 60 PTHrP 60 hypovitaminosis D 60 transgenic mouse models 60 mesangial 60 differentially expressed genes 60 cyclin E 60 KLF4 60 FGFs 60 CEACAM1 60 transthyretin 60 TGF β1 60 T2DM 60 P cadherin 60 tumorigenicity 60 juvenile idiopathic arthritis JIA 60 bronchoalveolar lavage BAL 60 hyperglycaemia 60 pyelonephritis 60 FGFR2 gene 60 arterial thickening 60 differential gene expression 60 autosomal dominant disorder 60 myeloperoxidase 60 mediated inhibition 60 malignant fibrous histiocytoma 60 lung metastasis 60 progesterone receptor negative 60 plasma folate 60 miRNA expression 60 neuroendocrine carcinoma 60 embryonal rhabdomyosarcoma 60 Hurthle cell 60 thyroid carcinomas 60 ependymomas 60 testicular tumors 60 histologically confirmed 60 renal pelvis 60 subclinical hypothyroidism 60 carcinomatosis 60 lymphocyte activation 60 urate levels 60 SE alleles 60 pancreatic carcinoma 60 TGFBR1 * 6A 60 cAMP signaling 60 nonfasting triglyceride levels 60 Prostatitis 60 periodontitis 60 adrenal cortex 60 serum triglycerides 60 thiazide 60 DQB1 * 60 small lymphocytic lymphoma 60 myocardial fibrosis 60 HMGA1 60 infantile hemangioma 60 IDH mutations 60 Atopic 60 idiopathic pulmonary 60 triiodothyronine 60 renal scarring 60 K#R [002] 59 bile duct cancers 59 PC# cells 59 Microalbuminuria 59 sequence homology 59 Prostatic 59 glycated hemoglobin levels 59 plasma kallikrein 59 AML MDS 59 Colon polyps 59 necrotizing 59 amyloid deposition 59 interleukin IL -# 59 axillary node 59 ESR1 59 Akt activation 59 enterovirus infection 59 stratifying patients 59 urothelial bladder cancer 59 WT1 59 HFE gene 59 colorectal polyps 59 angiosarcoma 59 adrenal function 59 nonfasting triglycerides 59 coexpression 59 hippocampal atrophy 59 Oesophageal cancer 59 Urinary tract 59 aminotransferase ALT 59 calcium excretion 59 dopamine receptor gene 59 duodenal ulcers 59 metastatic tumors 59 lymphangiogenesis 59 HER2 neu 59 #p# [003] 59 nondiabetic patients 59 allelic variants 59 FGFR2 59 ataxias 59 carcinoembryonic antigen 59 Autoantibodies 59 tumoral 59 mammographic density 59 histopathologic diagnosis 59 defensin 59 atherothrombotic 59 Subgroup analysis 59 KIF6 gene 59 situ LCIS 59 recurrent UTI 59 CD# expression [002] 59 elevated IOP 59 HCCs 59 obesity insulin resistance 59 dietary folate intake 59 neuropathologic 59 polycythemia vera PV 59 total thyroidectomy 59 syngeneic 59 Trichomonas vaginalis 59 TET2 59 homozygotes 59 Zinc deficiency 59 POAG 59 Oncogenic 59 atopic eczema 59 dyslipidaemia 59 promoter methylation 59 Magnesium deficiency 59 cisplatin resistant 59 oesophagitis 59 pleiotropic effects 59 haematopoietic 59 cardiovascular disease hypertension 59 monoclonal gammopathy 59 Sjogren syndrome 59 metastatic prostate 59 pre cancerous growths 59 serum phosphate 59 hereditary nonpolyposis colorectal cancer 59 serum uric acid 59 Inhibitory 59 antitumor efficacy 59 dysplastic lesions 59 perioperative complications 59 squamous cell cancers 59 Dental caries 59 Subgroup analyzes 59 clinicopathological features 59 antioxidant supplementation 59 PSADT 59 recessive inheritance 59 prostate adenocarcinoma 59 uPAR 59 Adjuvant therapy 59 chromosomal rearrangement 59 fluconazole resistant 59 anogenital 59 Cardiac hypertrophy 59 fibrogenesis 59 Nonspecific 59 probiotic supplementation 59 GSTM1 gene 59 CYT# potent vascular disrupting 59 Streptococcus pyogenes 59 BRCA mutation carriers 59 alpha synuclein protein 59 thyroid nodule 59 pancreatic endocrine 59 schwannomas 59 synovial cells 59 monozygotic twins 59 gastric cancer 59 geographic atrophy 59 myopathies 59 atopic 59 ERBB2 59 impaired glucose metabolism 59 Carcinoma 59 axillary lymph nodes 59 intestinal permeability 59 Carcinomas 59 genetic variants associated 59 serum antibodies 59 polyposis 59 phosphorylated tau 59 Barrett esophagus BE 59 colorectal liver metastases 59 thrombocytosis 59 IgG4 59 intracellular bacteria 59 lavage fluid 59 Benign breast 59 genetic polymorphism 59 chlamydial 59 goblet cells 59 Legg Calvé Perthes disease 59 tonsillar 59 cortisol secretion 59 myeloid leukemia 59 fibroma 59 TOP2A gene 59 extrapyramidal symptoms 59 progressive neurodegenerative disorder 59 interferon γ 59 Bcl xL 59 interstitial fibrosis 59 proliferative retinopathy 59 hypomethylation 59 squamous cell carcinomas 59 Helicobacter pylori H. pylori 59 ependymoma 59 completely resected 59 seminoma 59 antitrypsin 59 Cancer Incidence Mortality 59 glomerulonephritis 59 angiographically 59 obese postmenopausal 59 carcinomas 59 immunohistochemical staining 59 Polycythemia vera 59 epithelia 59 nitrotyrosine 59 Li Fraumeni syndrome 59 MLH1 59 inversely associated 59 intact parathyroid hormone 59 cerebrovascular diseases 59 node metastasis 59 eccrine 59 lymphoid tumors 59 Cystatin C 59 ABCB1 gene 59 MAPK pathway 59 luminal cells 59 vesicoureteral reflux VUR 59 L lysine 59 carcinoma 59 Henoch purpura 59 APOE ε4 59 Ribavirin causes 59 Lp PLA 2 59 Neisseria 59 aberrant activation 59 vivax 59 isoenzyme 59 colon carcinoma 59 extracapsular extension 59 2D 4D ratio 59 underlying pathophysiology 59 metabolic abnormality 59 Squamous Cell Carcinoma 59 gestational diabetes mellitus 59 Nonalcoholic Fatty Liver Disease 59 Nodules 59 Hypertrophic 59 parathyroid carcinoma 59 Endothelial dysfunction 59 elevated triglycerides 59 thyroid dysfunction 59 polycystic ovary syndrome PCOS 59 liver fibrosis 59 fasting glucose levels 59 Aß 59 IgA antibodies 59 motor neuron degeneration 59 breast cancer subtypes 59 p#NTR 59 bleomycin 59 malignant nodules 59 microangiopathy 59 TRAF1 C5 59 CYP#A# [002] 59 hypocalcaemia 59 SLC#A# [002] 59 coronary stenosis 59 nephrotoxicity 59 IL 1ß 59 acute leukemias 59 IGFBP2 59 susceptibility gene 59 Hyperlipidemia 59 pT3 59 herpesviruses 59 unresectable tumors 59 cryptogenic 59 silibinin 59 tertile 59 melanocytic nevi 59 tic severity 59 STRIDE PD